论文信息 - Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways. - 字舞流文

Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways.

Xi Chen | J. Liu | Y. Zhang | Naifeng Guo | Y. Cao | X-L Chen | Y-P Fan | X. Chen | Y-J Cao